LBBW Aktienanleihe MRK 27.09.2024/ DE000LB42QQ4 /
2024-07-23 1:15:10 PM | Chg.+0.730 | Bid1:20:25 PM | Ask1:20:25 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
99.640EUR | +0.74% | 99.580 Bid Size: 250,000 |
99.680 Ask Size: 250,000 |
MERCK KGAA O.N. | 140.00 - | 2024-09-27 | Call |
GlobeNewswire
06-03
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
GlobeNewswire
05-29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA